Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Cell. 2014 Nov 20;159(5):1110-1125. doi: 10.1016/j.cell.2014.10.013. Epub 2014 Nov 13.
lncRNAs are known to regulate a number of different developmental and tumorigenic processes. Here, we report a role for lncRNA BCAR4 in breast cancer metastasis that is mediated by chemokine-induced binding of BCAR4 to two transcription factors with extended regulatory consequences. BCAR4 binding of SNIP1 and PNUTS in response to CCL21 releases the SNIP1's inhibition of p300-dependent histone acetylation, which in turn enables the BCAR4-recruited PNUTS to bind H3K18ac and relieve inhibition of RNA Pol II via activation of the PP1 phosphatase. This mechanism activates a noncanonical Hedgehog/GLI2 transcriptional program that promotes cell migration. BCAR4 expression correlates with advanced breast cancers, and therapeutic delivery of locked nucleic acids (LNAs) targeting BCAR4 strongly suppresses breast cancer metastasis in mouse models. The findings reveal a disease-relevant lncRNA mechanism consisting of both direct coordinated protein recruitment and indirect regulation of transcription factors.
lncRNAs 已知可以调节许多不同的发育和肿瘤发生过程。在这里,我们报告了 lncRNA BCAR4 在乳腺癌转移中的作用,该作用是通过趋化因子诱导的 BCAR4 与两个转录因子结合介导的,这种结合具有广泛的调控后果。BCAR4 结合 SNIP1 和 PNUTS 以响应 CCL21 释放 SNIP1 对 p300 依赖性组蛋白乙酰化的抑制,这反过来又使 BCAR4 募集的 PNUTS 能够结合 H3K18ac 并通过激活 PP1 磷酸酶来解除对 RNA Pol II 的抑制。这种机制激活了非典型的 Hedgehog/GLI2 转录程序,促进细胞迁移。BCAR4 的表达与晚期乳腺癌相关,针对 BCAR4 的锁定核酸 (LNA) 的治疗性递送强烈抑制了小鼠模型中的乳腺癌转移。这些发现揭示了一种与疾病相关的 lncRNA 机制,包括直接协调蛋白募集和间接调节转录因子。